Children are often prescribed antibiotics inappropriately in the outpatient setting. The harms of this practice are poorly characterized but could inform risk-benefit discussions with parents.
GLP-1 receptor agonists are commonly used as pharmacotherapy for weight loss in patients with obesity. What’s the evidence?
PrEP coverage is marked by significant disparities across race/ethnicity. What’s happening in RI to combat this?
We use glucocorticoid medications (often simply called steroids) all the time, but the potential side effects are many!
FDA’s Risk Evaluation and Mitigation Strategy (REMS) is a drug safety program required for certain medications, including mifepristone, to ensure that the benefits of the medication outweigh the risks.
Obesity is incredibly complex, which allows for a variety of management approaches.
What’s the difference between PrEP and PEP? How effective are they? Who’s eligible?
Do you know the indications for giving Synagis to infants at high risk for RSV?
Buprenorphine is a safe medication that can change people’s lives.
Did you know that there’s only one non-stimulant medication approved for treatment of ADHD in adults?